| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |